with its ability to promote MOP-receptor endocytosis 1B) and in rat brain (Figures 1D and 1E) . We utilized ( Figures 1A and 1B) . methadone, in particular the mixed dl-enantiomer of We next examined whether a subendocytic dose of this drug, for these studies because it is widely availdl-methadone (50 nmol), which facilitated morphineable and inexpensive to produce, and the mixed enantiinduced endocytosis in vivo ( Figures 1D and 1E) , could omer is the drug principally used clinically [5]. As affect the development of either morphine tolerance or shown previously [6], saturating doses of methadone morphine dependence. First, rats were implanted with (1 M) promote endocytosis of the MOP receptor, a catheter intracerebroventricularly (i.c.v.) through which whereas saturating doses of morphine (1 M) do not drug or drug combinations were administered twice ( Figure 1A) . We propose, then, that methadone-and daily. We chose a morphine dose (30 nmol) that gave morphine-occupied receptors are in different activated about 80% maximal possible effect (MPE) in the tailconformations, whereby the methadone-activated conflick test to insure that both decreases and increases formation better engages the endocytic machinery. We in analgesia could be detected. attribute the ability of a small number of dl-methadoneRats treated with morphine alone developed proactivated receptors to facilitate endocytosis of the morfound tolerance by day 5 (Figure 2A , red line, open cirphine-activated receptors to the oligomeric nature of cle, p < .001 day 1 versus day 5). dl-methadone alone the opioid receptors [7]. Specifically, we propose that (50 nmol, black line, closed circle) produced no analgesia at this dose, nor did dl-methadone enhance acute morphine analgesia on day 1 (Figure 2A , compare red
First, we examined whether NR1 or NR2A were upregulated after the chronic morphine treatment utiWe propose that endocytosis of the MOP receptor in response to morphine is reducing tolerance and depenlized for our behavioral experiments. Expression of NR1 and NR2A ( Figures 4A and 4B) was assessed in several dence, at least in part, by reducing superactivation of the cAMP pathway (Figure 1; see [20] ). However, there brain regions after the behavioral experiments in Figure  2A . There was a trend toward upregulation of both NR1 are several additional biochemical markers that have
